• 

  We need more tankers for oxygen supply: Haryana CM

  News | May 05, 2021 23:39 IST

  Chief Minister of Haryana, Manohar Lal Khattar said that control room for oxygen supply has been made in Chandigarh amid soared requirement of oxygen in the state.

• 

  Tocilizumab may improve survival in sickest COVID-19 patients, scientists say

  World | August 21, 2020 18:28 IST

  Among other treatments, they said tocilizumab was considered for off-label usage for the patients whose respiratory symptoms were declining -- many of whom were requiring mechanical ventilator support.

• 

  Health ministry asks DCGI to ensure equitable distribution of Remdesivir, Tocilizumab drugs

  India | July 29, 2020 21:07 IST

  The Union health ministry has asked the Drugs Controller General of India to ensure equitable distribution of Remdesivir and Tocilizumab drugs, which have been included as "investigational therapies" in the national treatment protocols for COVID-19, across the country.

• 

  Indiscriminate use of remdesivir, tocilizumab on COVID-19 patients can cause more harm than good

  India | July 11, 2020 20:38 IST

  The Indian Council of Medical Research (ICMR) and the All India Institute of Medical Sciences (AIIMS) have asked states to use drugs like remdesivir and tocilizumab, mentioned as investigational therapies, on COVID-19 patients strictly as per the laid down protocol as their "indiscriminate use or use in conditions for which they are not desirable may cause more harm than good".

• 

  Remdesivir, tocilizumab being considered for 'restricted use' on severely ill COVID-19 patients

  India | June 11, 2020 16:46 IST

  Anti-viral drug remdesivir and tocilizumab, an immunomodulator, are being considered for "restricted use" on severely ill COVID-19 patients on "emergency and compassionate grounds", according to revised clinical management guidelines to be released soon.

• 

  Tocilizumab drug may help fight severe coronavirus cases, study finds

  News | May 01, 2020 14:38 IST

  An antibody treatment, using the drug tocilizumab, may be represented as an effective option in severe coronavirus cases, according to a preliminary report by Xiaoling Xu et al, published in PNAS.